A Multicenter, Randomized, Double-blind, Placebo-control

Project: Research project

Project Details

Description

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Alogliptin Compared with Placebo in Pediatric Subjects With Type 2 Diabetes Mellitus
StatusActive
Effective start/end date5/1/1810/31/21

Funding

  • The EMMES Corporation

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.